| Product Code: ETC7474066 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Hong Kong`s CIS insulin import market saw a significant shift in concentration levels, moving from very high concentration in 2023 to moderate concentration. Top exporting countries like Germany, USA, Austria, China, and South Korea continue to dominate the market. However, the market experienced a steep decline with a CAGR of -19.16% from 2020 to 2024, and a drastic growth rate drop of -79.3% from 2023 to 2024. This suggests a challenging environment for insulin importers in Hong Kong, signaling the need for strategic adaptation to market dynamics.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hong Kong CIS Insulin Market Overview |
3.1 Hong Kong Country Macro Economic Indicators |
3.2 Hong Kong CIS Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Hong Kong CIS Insulin Market - Industry Life Cycle |
3.4 Hong Kong CIS Insulin Market - Porter's Five Forces |
3.5 Hong Kong CIS Insulin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Hong Kong CIS Insulin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Hong Kong CIS Insulin Market Revenues & Volume Share, By Source, 2021 & 2031F |
4 Hong Kong CIS Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in Hong Kong |
4.2.2 Growing awareness about the importance of insulin therapy |
4.2.3 Technological advancements in insulin delivery systems |
4.3 Market Restraints |
4.3.1 High cost associated with insulin therapy |
4.3.2 Limited access to healthcare services in some regions of Hong Kong |
4.3.3 Stringent regulatory requirements for insulin products |
5 Hong Kong CIS Insulin Market Trends |
6 Hong Kong CIS Insulin Market, By Types |
6.1 Hong Kong CIS Insulin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Hong Kong CIS Insulin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Hong Kong CIS Insulin Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.1.4 Hong Kong CIS Insulin Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.2 Hong Kong CIS Insulin Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Hong Kong CIS Insulin Market Revenues & Volume, By Rapid Acting, 2021- 2031F |
6.2.3 Hong Kong CIS Insulin Market Revenues & Volume, By Long Acting, 2021- 2031F |
6.2.4 Hong Kong CIS Insulin Market Revenues & Volume, By Short Acting, 2021- 2031F |
6.2.5 Hong Kong CIS Insulin Market Revenues & Volume, By Intermediate Acting, 2021- 2031F |
6.2.6 Hong Kong CIS Insulin Market Revenues & Volume, By Premixed, 2021- 2031F |
6.3 Hong Kong CIS Insulin Market, By Source |
6.3.1 Overview and Analysis |
6.3.2 Hong Kong CIS Insulin Market Revenues & Volume, By Analog, 2021- 2031F |
6.3.3 Hong Kong CIS Insulin Market Revenues & Volume, By Human Recombinant, 2021- 2031F |
7 Hong Kong CIS Insulin Market Import-Export Trade Statistics |
7.1 Hong Kong CIS Insulin Market Export to Major Countries |
7.2 Hong Kong CIS Insulin Market Imports from Major Countries |
8 Hong Kong CIS Insulin Market Key Performance Indicators |
8.1 Average time taken for insulin product approvals by regulatory authorities |
8.2 Adoption rate of new insulin delivery technologies in the market |
8.3 Percentage of diabetic population in Hong Kong using insulin therapy |
9 Hong Kong CIS Insulin Market - Opportunity Assessment |
9.1 Hong Kong CIS Insulin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Hong Kong CIS Insulin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Hong Kong CIS Insulin Market Opportunity Assessment, By Source, 2021 & 2031F |
10 Hong Kong CIS Insulin Market - Competitive Landscape |
10.1 Hong Kong CIS Insulin Market Revenue Share, By Companies, 2024 |
10.2 Hong Kong CIS Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |